In this episode, we sit down with Nicholas Kadysh, CEO of PharmAla Biotech, the company pioneering GMP MDMA production and recognized as the top-performing stock on the Canadian capital markets in 2023 by The Market Herald.
As Chair of Psychedelics Canada, Nicholas has played a pivotal role in strengthening legal and ethical standards for the industry, while driving government engagement and public policy that support innovation in healthcare. His leadership and vision were further acknowledged in 2023, when The Peak honored him for emerging leadership in healthcare.
Join us for a conversation on biotech innovation, the evolving future of psychedelic medicine, and how policy is shaping a new landscape in healthcare.
